PEOPLE - BioTransplant (US) makes appointment:
This article was originally published in Clinica
BioTransplant (Charlestown, Massachusetts) has announced the appointment of Barbara Wallner as chief scientific officer. Dr Wallner most recently served as senior vice-president of R&D and chief scientific officer at Point Therapeutics - a company she co-founded five years ago.
You may also be interested in...
Canada has announced new restrictions on exports to help mitigate the impact of measures in the US to lower medicine prices there.
The US agency says in the latest update to its medical device shortages guidance doc that it’ll send enforcement missives to companies that don’t notify the agency of a “permanent discontinuance or an interruption in manufacturing” of products deemed critical during the COVID-19 pandemic.
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.